Acetoxymethylketobemidone Explained

Acetoxymethylketobemidone (O-AMKD), is an opioid designer drug related to ketobemidone, with around the same potency as morphine. It was first identified in Germany in October 2020.^{[1] [2]}

See also

• 2F-Viminol
• 3-HO-PCP
• 4-Fluoropethidine
• Acetoxyketobemidone
• Bucinnazine
• Dipyanone
• Etodesnitazene
• Methylketobemidone
• Nortilidine
• O-Desmethyltramadol
• Piperidylthiambutene
• Propylketobemidone

Notes and References

1. New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. . An Update from the EU Early Warning System . European Monitoring Center for Drugs and Drug Addiction . Luxembourg . Publications Office of the European Union . December 2020 . 10.2810/921262 . 9789294975584 .
2. Lamy FR, Daniulaityte R, Barratt MJ, Lokala U, Sheth A, Carlson RG . "Etazene, safer than heroin and fentanyl": Non-fentanyl novel synthetic opioid listings on one darknet market . Drug and Alcohol Dependence . 225 . 108790 . August 2021 . 34091156 . 10.1016/j.drugalcdep.2021.108790 . 235362241 .